{"article_link": "https://www.frontiersin.org/articles/10.3389/fgene.2020.616435/full", "data": [{"id": "data_1", "omics": "Transcriptomics", "link": "https://www.ncbi.nlm.nih.gov/sra/?term=SRP237545", "format": "fastq", "source": "Sequence Read Archive (SRA)", "public_id": "SRP237545"}, {"id": "data_2", "omics": "Proteomics", "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE142025", "format": "txt", "source": "Gene Expression Omnibus (GEO)", "public_id": "GSE142025"}, {"id": "data_3", "omics": "Metabolomics", "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE142025", "format": "txt", "source": "Gene Expression Omnibus (GEO)", "public_id": "GSE142025"}], "analyses": [{"id": "analysis_1", "analysis_type": "RNA-seq", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"group": ["Early-stage Diabetic Nephropathy Patients", "Healthy Controls"]}}, {"id": "analysis_2", "analysis_type": "Differential analysis", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"group": ["Early-stage Diabetic Nephropathy Patients", "Healthy Controls"]}}, {"id": "analysis_3", "analysis_type": "Differential analysis", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"group": ["Advanced-stage Diabetic Nephropathy Patients", "Healthy Controls"]}}, {"id": "analysis_4", "analysis_type": "Weighted correlation network analysis (WGCNA)", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"group": ["Early-stage Diabetic Nephropathy Patients", "Advanced-stage Diabetic Nephropathy Patients", "Healthy Controls"]}}, {"id": "analysis_5", "analysis_type": "KEGG enrichment analysis", "analysis_data": ["analysis_4"], "training_set": [], "test_set": [], "label": {"module": ["Turquoise Module", "Blue Module"]}}, {"id": "analysis_6", "analysis_type": "iTRAQ-based protein quantification", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"group": ["db/db Mice (18 weeks)", "db/m Control Mice"]}}, {"id": "analysis_7", "analysis_type": "Differential analysis", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"group": ["db/db Mice (18 weeks)", "db/m Control Mice"]}}, {"id": "analysis_8", "analysis_type": "Gene Set Enrichment Analysis (GSEA)", "analysis_data": ["analysis_7"], "training_set": [], "test_set": [], "label": {"group": ["db/db Mice (18 weeks)", "db/m Control Mice"]}}, {"id": "analysis_9", "analysis_type": "Protein–protein interaction network using STRING and Cytoscape", "analysis_data": ["analysis_7"], "training_set": [], "test_set": [], "label": {"group": ["db/db Mice (18 weeks)", "db/m Control Mice"]}}, {"id": "analysis_10", "analysis_type": "Untargeted metabolomics using LC-MS/MS", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"group": ["db/db Mice (12 weeks)", "db/db Mice (18 weeks)", "db/m Control Mice"]}}, {"id": "analysis_11", "analysis_type": "Principal Component Analysis (PCA)", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"group": ["db/db Mice (12 weeks)", "db/db Mice (18 weeks)", "db/m Control Mice"]}}, {"id": "analysis_12", "analysis_type": "Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA)", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"group": ["db/db Mice (12 weeks)", "db/db Mice (18 weeks)", "db/m Control Mice"]}}, {"id": "analysis_13", "analysis_type": "Differential analysis", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"group": ["db/db Mice (12 weeks)", "db/db Mice (18 weeks)", "db/m Control Mice"]}}, {"id": "analysis_14", "analysis_type": "KEGG pathway enrichment", "analysis_data": ["analysis_13"], "training_set": [], "test_set": [], "label": {"group": ["db/db Mice (12 weeks)", "db/db Mice (18 weeks)", "db/m Control Mice"]}}, {"id": "analysis_15", "analysis_type": "Differential analysis", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"group": ["db/db Mice (12 weeks)", "db/db Mice (18 weeks)"]}}, {"id": "analysis_16", "analysis_type": "KEGG pathway enrichment", "analysis_data": ["analysis_15"], "training_set": [], "test_set": [], "label": {"group": ["db/db Mice (12 weeks)", "db/db Mice (18 weeks)"]}}, {"id": "analysis_17", "analysis_type": "Integration of transcriptomic, proteomic, and metabolomic data", "analysis_data": ["analysis_5", "analysis_8", "analysis_14", "analysis_16"], "training_set": [], "test_set": [], "label": {"integration": ["Transcriptome", "Proteome", "Metabolome"]}}], "results": [{"analysis_id": "analysis_1", "metric": "PCA segregation", "value": "Advanced-stage DN samples significantly segregated from healthy controls", "features": []}, {"analysis_id": "analysis_2", "metric": "Fold change", "value": "> 2 or < 0.5", "features": ["115 up-regulated genes", "193 down-regulated genes", "CXCL12", "IL-6", "CXCL8", "CCL20", "CXCL1", "IL1B", "MIR29A", "MIR4521", "PABPC5-AS1", "AL353600.2"]}, {"analysis_id": "analysis_3", "metric": "Fold change", "value": "> 2 or < 0.5", "features": ["3,135 up-regulated genes", "1,372 down-regulated genes", "IL-6", "CXCL3", "CCL5", "CYP26B1", "CYP4A22", "COX5BP1"]}, {"analysis_id": "analysis_4", "metric": "Correlation", "value": "R = 0.80, P < 0.001 (Turquoise Module); R = 0.63, P < 0.001 (Blue Module); R = 0.67, P < 0.001 (Brown Module)", "features": ["Turquoise Module (3,143 genes)", "Blue Module (1,282 genes)", "Brown Module (104 genes)"]}, {"analysis_id": "analysis_5", "metric": "Enrichment", "value": "Significant", "features": ["Turquoise Module: Cytokine–cytokine receptor interaction, JAK-STAT signaling pathway, T cell receptor signaling pathway, Extracellular Matrix (ECM) construction", "Blue Module: Retinol metabolism, Glucagon signaling pathway, Glycine, serine and threonine metabolism, Linoleic acid metabolism, Fat digestion and absorption, Oxidative phosphorylation, Drug metabolism"]}, {"analysis_id": "analysis_6", "metric": "PCA segregation", "value": "db/db samples significantly segregated from db/m control samples", "features": []}, {"analysis_id": "analysis_7", "metric": "Fold change", "value": "> 2 or < 0.5", "features": ["210 up-regulated proteins", "119 down-regulated proteins", "Cox2", "Acox1", "Acox2", "Acox3", "Acms1", "Acms3"]}, {"analysis_id": "analysis_8", "metric": "Enrichment", "value": "Significant", "features": ["Fatty-acids metabolism", "Fatty-acids β-oxidation", "Fatty-acids biosynthesis"]}, {"analysis_id": "analysis_9", "metric": "Network analysis", "value": "Co-inhibited", "features": ["Cox2", "Acox1", "Acox2", "Acox3", "Acms1", "Acms3"]}, {"analysis_id": "analysis_10", "metric": "PCA segregation", "value": "db/db samples significantly segregated from db/m control samples", "features": []}, {"analysis_id": "analysis_11", "metric": "PCA segregation", "value": "db/db samples significantly segregated from db/m control samples", "features": []}, {"analysis_id": "analysis_12", "metric": "Modeling", "value": "Significant", "features": []}, {"analysis_id": "analysis_13", "metric": "Fold change", "value": "> 2 or < 0.5", "features": ["28 up-regulated metabolites", "154 down-regulated metabolites", "(±)10(11)-EpDPA", "(±)9-HpODE", "(±)13-HODE", "Linoleic Acid", "Docosahexaenoic Acid"]}, {"analysis_id": "analysis_14", "metric": "Enrichment", "value": "Significant", "features": ["Sphingolipid metabolism", "Biosynthesis of unsaturated fatty acids", "alpha-Linolenic acid metabolism"]}, {"analysis_id": "analysis_15", "metric": "Fold change", "value": "> 2 or < 0.5", "features": ["32 up-regulated metabolites", "30 down-regulated metabolites", "(±)9-HpODE", "Linoleic Acid"]}, {"analysis_id": "analysis_16", "metric": "Enrichment", "value": "Significant", "features": ["Sphingolipid metabolism", "Linoleic acid metabolism"]}, {"analysis_id": "analysis_17", "metric": "Integration", "value": "Lipid metabolism (linoleic acid metabolism and fatty-acids β-oxidation) is significantly inhibited", "features": ["ABCD3", "ACOX1", "ACOX2", "ACOX3", "13'-HODE", "Stearidonic Acid", "Docosahexaenoic Acid", "(±)10(11)-EpDPA"]}]}